<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33436868</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>803</StartPage><MedlinePgn>803</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">803</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-80378-y</ELocationID><Abstract><AbstractText>Aberrant cholesterol homeostasis is implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disease that is due to motor neuron (MN) death. Cellular toxicity from excess cholesterol is averted when it is enzymatically oxidized to oxysterols and bile acids (BAs) to promote its removal. In contrast, the auto oxidation of excess cholesterol is often detrimental to cellular survival. Although oxidized metabolites of cholesterol are altered in the blood and CSF of ALS patients, it is unknown if increased cholesterol oxidation occurs in the SC during ALS, and if exposure to oxidized cholesterol metabolites affects human MN viability. Here, we show that in the SOD1<sup>G93A</sup> mouse model of ALS that several oxysterols, BAs and auto oxidized sterols are increased in the lumbar SC, plasma, and feces during disease. Similar changes in cholesterol oxidation were found in the cervical SC of sporadic ALS patients. Notably, auto-oxidized sterols, but not oxysterols and BAs, were toxic to iPSC derived human MNs. Thus, increased cholesterol oxidation is a manifestation of ALS and non-regulated sterol oxidation likely contributes to MN death. Developing therapeutic approaches to restore cholesterol homeostasis in the SC may lead to a treatment for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dodge</LastName><ForeName>James C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area, Sanofi R+D, 49 New York Avenue, Framingham, MA, 01701, USA. james.dodge@sanofi.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jinlong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area, Sanofi R+D, 49 New York Avenue, Framingham, MA, 01701, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardi</LastName><ForeName>S Pablo</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area, Sanofi R+D, 49 New York Avenue, Framingham, MA, 01701, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shihabuddin</LastName><ForeName>Lamya S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Rare and Neurological Diseases Therapeutic Area, Sanofi R+D, 49 New York Avenue, Framingham, MA, 01701, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN275200900011C</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013261">Sterols</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013261" MajorTopicYN="N">Sterols</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors are employees of Sanofi.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33436868</ArticleId><ArticleId IdType="pmc">PMC7804278</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-80378-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-80378-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li P, et al. A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell Metab. 2015;21:455&#x2013;467. doi: 10.1016/j.cmet.2015.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.02.004</ArticleId><ArticleId IdType="pmc">PMC4350020</ArticleId><ArticleId IdType="pubmed">25738460</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang PM, et al. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc. Natl. Acad. Sci. USA. 2010;107:16320&#x2013;16324. doi: 10.1073/pnas.1002176107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002176107</ArticleId><ArticleId IdType="pmc">PMC2941284</ArticleId><ArticleId IdType="pubmed">20660762</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang J. C9orf72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism. Autophagy. 2019;15:913&#x2013;914. doi: 10.1080/15548627.2019.1580106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1580106</ArticleId><ArticleId IdType="pmc">PMC6526819</ArticleId><ArticleId IdType="pubmed">30767689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lastres-Becker I, et al. Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum. Mol. Genet. 2008;17:1465&#x2013;1481. doi: 10.1093/hmg/ddn035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn035</ArticleId><ArticleId IdType="pubmed">18250099</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouzat K, et al. Liver X receptor genes variants modulate ALS phenotype. Mol. Neurobiol. 2018;55:1959&#x2013;1965. doi: 10.1007/s12035-017-0453-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0453-2</ArticleId><ArticleId IdType="pubmed">28244008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanhueza M, et al. Network analyses reveal novel aspects of ALS pathogenesis. PLoS Genet. 2015;11:e1005107. doi: 10.1371/journal.pgen.1005107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005107</ArticleId><ArticleId IdType="pmc">PMC4380362</ArticleId><ArticleId IdType="pubmed">25826266</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokutake Y, Gushima K, Miyazaki H, Shimosato T, Yonekura S. ALS-associated P56S-VAPB mutation restrains 3T3-L1 preadipocyte differentiation. Biochem. Biophys. Res. Commun. 2015;460:831&#x2013;837. doi: 10.1016/j.bbrc.2015.03.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.03.118</ArticleId><ArticleId IdType="pubmed">25824044</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CY, et al. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism. Hum. Mol. Genet. 2014;23:319&#x2013;332. doi: 10.1093/hmg/ddt422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt422</ArticleId><ArticleId IdType="pmc">PMC3869353</ArticleId><ArticleId IdType="pubmed">24001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris LL, Hartman IZ, Jun DJ, Seemann J, DeBose-Boyd RA. Sequential actions of the AAA-ATPase valosin-containing protein (VCP)/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 2014;289:19053&#x2013;19066. doi: 10.1074/jbc.M114.576652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.576652</ArticleId><ArticleId IdType="pmc">PMC4081943</ArticleId><ArticleId IdType="pubmed">24860107</ArticleId></ArticleIdList></Reference><Reference><Citation>Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol. Sci. 2010;31:557&#x2013;566. doi: 10.1016/j.tips.2010.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC2993063</ArticleId><ArticleId IdType="pubmed">20869780</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore F, Riordan JF. Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells. Biochemistry. 1990;29:228&#x2013;233. doi: 10.1021/bi00453a031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00453a031</ArticleId><ArticleId IdType="pubmed">2322543</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman KM, et al. Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation. Glia. 2020;68:2040&#x2013;2056. doi: 10.1002/glia.23825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23825</ArticleId><ArticleId IdType="pmc">PMC7772959</ArticleId><ArticleId IdType="pubmed">32187401</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol. 2011;258:613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yazdani S, Piehl F, Magnusson PKE, Fang F. Polygenic link between blood lipids and amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;67(202):e201&#x2013;e202. doi: 10.1016/j.neurobiolaging.2018.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.03.022</ArticleId><ArticleId IdType="pubmed">29685649</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann. Neurol. 2017;81:718&#x2013;728. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 2002;52:448&#x2013;457. doi: 10.1002/ana.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10312</ArticleId><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, et al. Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis. J. Neurosci. 2020;40:9137&#x2013;9147. doi: 10.1523/JNEUROSCI.1388-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1388-20.2020</ArticleId><ArticleId IdType="pmc">PMC7673008</ArticleId><ArticleId IdType="pubmed">33051352</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AB, et al. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci. Rep. 2019;9:11642. doi: 10.1038/s41598-019-48059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J, et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J. Lipid Res. 2017;58:267&#x2013;278. doi: 10.1194/jlr.P071639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Steck TL, Lange Y. Cell cholesterol homeostasis: mediation by active cholesterol. Trends Cell Biol. 2010;20:680&#x2013;687. doi: 10.1016/j.tcb.2010.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC2967630</ArticleId><ArticleId IdType="pubmed">20843692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, et al. 25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis. Oncotarget. 2017;8:11855&#x2013;11867. doi: 10.18632/oncotarget.14416.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14416</ArticleId><ArticleId IdType="pmc">PMC5355309</ArticleId><ArticleId IdType="pubmed">28060747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A, et al. Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor. PLoS ONE. 2014;9:e113619. doi: 10.1371/journal.pone.0113619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113619</ArticleId><ArticleId IdType="pmc">PMC4240598</ArticleId><ArticleId IdType="pubmed">25415378</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilopoulos S, et al. Cholestenoic acids regulate motor neuron survival via liver X receptors. J. Clin. Investig. 2014;124:4829&#x2013;4842. doi: 10.1172/JCI68506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI68506</ArticleId><ArticleId IdType="pmc">PMC4347238</ArticleId><ArticleId IdType="pubmed">25271621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutemberezi V, Guillemot-Legris O, Muccioli GG. Oxysterols: from cholesterol metabolites to key mediators. Prog. Lipid Res. 2016;64:152&#x2013;169. doi: 10.1016/j.plipres.2016.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2016.09.002</ArticleId><ArticleId IdType="pubmed">27687912</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfrieger FW, Ungerer N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 2011;50:357&#x2013;371. doi: 10.1016/j.plipres.2011.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2011.06.002</ArticleId><ArticleId IdType="pubmed">21741992</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. USA. 2008;105:17913&#x2013;17918. doi: 10.1073/pnas.0804610105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804610105</ArticleId><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogundare M, et al. Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain? J. Biol. Chem. 2010;285:4666&#x2013;4679. doi: 10.1074/jbc.M109.086678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.086678</ArticleId><ArticleId IdType="pmc">PMC2836072</ArticleId><ArticleId IdType="pubmed">19996111</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Martelot G, et al. REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol. 2009;7:e1000181. doi: 10.1371/journal.pbio.1000181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000181</ArticleId><ArticleId IdType="pmc">PMC2726950</ArticleId><ArticleId IdType="pubmed">19721697</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC. Lipid involvement in neurodegenerative diseases of the motor system: insights from lysosomal storage diseases. Front. Mol. Neurosci. 2017;10:356. doi: 10.3389/fnmol.2017.00356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00356</ArticleId><ArticleId IdType="pmc">PMC5675881</ArticleId><ArticleId IdType="pubmed">29163032</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan G, Xie C, Dietschy JM, Turley SD. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res. Dev. Brain Res. 2003;146:87&#x2013;98. doi: 10.1016/j.devbrainres.2003.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devbrainres.2003.09.015</ArticleId><ArticleId IdType="pubmed">14643015</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson GM, Dayas CV, Smith DW. Perturbed cholesterol homeostasis in aging spinal cord. Neurobiol. Aging. 2016;45:123&#x2013;135. doi: 10.1016/j.neurobiolaging.2016.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.05.017</ArticleId><ArticleId IdType="pubmed">27459933</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarilio R, Ramachandran S, Sabanay H, Lev S. Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 2005;280:5934&#x2013;5944. doi: 10.1074/jbc.M409566200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409566200</ArticleId><ArticleId IdType="pubmed">15545272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolo AP, Palmeira CM, Holy JM, Wallace KB. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. Toxicol. Sci. 2004;79:196&#x2013;204. doi: 10.1093/toxsci/kfh078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfh078</ArticleId><ArticleId IdType="pubmed">14976352</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A, Kaushik N, de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 2001;77:132&#x2013;145. doi: 10.1046/j.1471-4159.2001.t01-1-00231.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.t01-1-00231.x</ArticleId><ArticleId IdType="pubmed">11279269</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto W, et al. O'Sullivan-McLeod syndrome: Unmasking a rare atypical motor neuron disease. Rev. Neurol. (Paris) 2019;175:81&#x2013;86. doi: 10.1016/j.neurol.2018.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2018.04.009</ArticleId><ArticleId IdType="pubmed">30409480</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen H, et al. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J. Biol. Chem. 1998;273:14805&#x2013;14812. doi: 10.1074/jbc.273.24.14805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.24.14805</ArticleId><ArticleId IdType="pubmed">9614081</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331&#x2013;340. doi: 10.1016/S0092-8674(00)80213-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80213-5</ArticleId><ArticleId IdType="pubmed">9150132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS, Boillee S, Cleveland DW. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc. Natl. Acad. Sci. USA. 2007;104:7319&#x2013;7326. doi: 10.1073/pnas.0702230104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0702230104</ArticleId><ArticleId IdType="pmc">PMC1863491</ArticleId><ArticleId IdType="pubmed">17463094</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson S, Gustafsson N, Warner M, Gustafsson JA. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc. Natl. Acad. Sci. USA. 2005;102:3857&#x2013;3862. doi: 10.1073/pnas.0500634102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0500634102</ArticleId><ArticleId IdType="pmc">PMC553330</ArticleId><ArticleId IdType="pubmed">15738425</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003;72:137&#x2013;174. doi: 10.1146/annurev.biochem.72.121801.161712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161712</ArticleId><ArticleId IdType="pubmed">12543708</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WW, et al. Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse. Exp. Neurol. 2011;227:287&#x2013;295. doi: 10.1016/j.expneurol.2010.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2010.11.019</ArticleId><ArticleId IdType="pubmed">21145892</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Urano Y, Takabe W, Saito Y, Noguchi N. Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA:cholesterol acyltransferase 1. Cell Death Dis. 2014;5:e990. doi: 10.1038/cddis.2013.524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.524</ArticleId><ArticleId IdType="pmc">PMC4040651</ArticleId><ArticleId IdType="pubmed">24407243</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;1008. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullrich C, Pirchl M, Humpel C. Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices. Pharmacology. 2010;86:15&#x2013;21. doi: 10.1159/000314333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000314333</ArticleId><ArticleId IdType="pmc">PMC4311142</ArticleId><ArticleId IdType="pubmed">20571288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Cell death induced by 7-oxysterols via lysosomal and mitochondrial pathways is p53-dependent. Free Radic. Biol. Med. 2012;53:2054&#x2013;2061. doi: 10.1016/j.freeradbiomed.2012.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.09.007</ArticleId><ArticleId IdType="pubmed">22985798</ArticleId></ArticleIdList></Reference><Reference><Citation>Nury T, et al. Induction of oxiapoptophagy, a mixed mode of cell death associated with oxidative stress, apoptosis and autophagy, on 7-ketocholesterol-treated 158N murine oligodendrocytes: impairment by alpha-tocopherol. Biochem. Biophys. Res. Commun. 2014;446:714&#x2013;719. doi: 10.1016/j.bbrc.2013.11.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.11.081</ArticleId><ArticleId IdType="pubmed">24299956</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, et al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc. Natl. Acad. Sci. USA. 2013;110:10812&#x2013;10817. doi: 10.1073/pnas.1308421110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308421110</ArticleId><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidler JA, et al. Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. FASEB J. 2011;25:4369&#x2013;4377. doi: 10.1096/fj.11-190819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-190819</ArticleId><ArticleId IdType="pmc">PMC3236626</ArticleId><ArticleId IdType="pubmed">21876068</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>